Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
MA has seen an exponential growth over the last decade as it value and place within the pharmaceutical industry is being realised. The evolution of MA from a support function to strategic partner has changed the direction of MA and also required an evolution of skill sets for the roles which underpin MA.
As a profession, there is still a void with a globally recognised advanced scientific qualification, capability frameworks across the main 3 role types and accreditation.
This collaborative webinar aims to discuss available postgraduate courses and insights from alumni into how their qualification helped advance their understanding of pharmaceutical medicine and their career.
At the conclusion of this session, participants should better understand digital trends seen within Medical Affairs today as well as be aware of why HCP expectations are changing and how to evolve with them to provide better customer experiences.
A Look at Customer Experiences Inside and Outside of the Industry and What It Means for Medical Affairs
Medical Affairs professionals must engage with multiple stakeholders in healthcare delivery, including clinicians, patients, payers and policy makers. Each of these audiences is focused on different value drivers and requires specialized communications and messaging to make informed decisions. Traditional scientific communications platform (SCP) usage is usually limited to the Medical team. Internal functions focused on other audiences (e.g. payers, patients, policy makers) often create their own message frameworks, duplicating efforts and potentially leading to misalignment. Increasingly, audiences expect to be informed of the bigger picture and to contribute to the wider value story through direct interactions with other stakeholder groups. HealthScience brings together clinical, economic, social, behavioral and policy perspectives to demonstrate therapeutic value in healthcare systems. The HealthScience approach can be used to expand the concepts and content of the SCP to provide an integrated engagement plan and proposals for evidence generation. At the conclusion of this session, participants should:
Understand the latest technologies—Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and Natural Language Understanding (NLU). Understand the potential of these technologies to increase efficiencies, enhance effectiveness and potentially reduce compliance risk.
At the conclusion of this session, participants should:
• Better understand contemporary digital trends of Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and Natural Language Understanding (NLU)
As HCP reliance upon digital and social channels as both a source of educational information and a central meeting place for peer-to-peer interaction continues to increase, it’s critical for Medical Affairs teams to monitor that activity, understand who the Digital Opinion Leaders (DOLs) are and engage them appropriately.
In this session we will provide perspectives on the evolving role of Digital Opinion Leaders in medical education and share approaches for identifying, monitoring and engaging them in a compliant manor with relevant examples.
This series will provide you with tools to critically process and analyze medical scientific literature. You will get a good understanding of basic statistical concepts and theory that enable you to explain, understand and interpret data. These Webinars are practical and based on published articles and the analysis of these. You will work with the theory in practice to increase your understanding of the strengths and weaknesses of the statistics in scientific literature.
Statistical analysis in clinical trials
– Null/alternative hypotheses
– Statistical assumptions (type I error, significance level, type II error, statistical power,)
– Hypothesis testing
– Statistical tests
Statistics used in RCTs
– Type of outcome measures (dichotomous, continuous, time-to-event)
– Statistics used for analysis of dichotomous data (relative risk, odds ratio, risk difference, NNT)
– Analysis of time-to-event variables (plotting and interpretation of Kaplan-Meier curves)
Early Access includes a variety of programs by which pharmaceutical companies make investigational therapies available to patients with life-threatening diseases. These patients have either exhausted available treatments or have no approved options. This presentation will review the processes and procedures to consider in the implementation of an Early Access Program and explore the opportunities and challenges posed therein.
At the end of this webinar the participant will be able to:
At the conclusion of this eCademy Webinar, participants will be better able to understand:
As healthcare continues to transform, we need to stay connected to our customers in many ways. From Upstream scientific exchange driving research, to clinical trial design establishing evidence, to co-creation workshops establishing value propositions, to education and post-release support to drive adoption, collaboration with customers across the solution lifecycle is key to providing the best solutions to our customers. MSLs are becoming more important and playing key roles across the lifecycle in partnership with many others who play important roles. We will describe the landscape, drivers, and opportunities for engaging with customers across the lifecycle and how we socialize learnings across the organization.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.